Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
24/7 Access to USA Board Certified Doctor Support Youll have round-the-clock access to our partnering board-certified doctors
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
,
Our licensed medical providers evaluate each patient individually to determine whether this medication may be an appropriate part of a comprehensive medical weight loss plan
